Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for ArQule, Inc. (ARQL)

« Back to company index

ARQL Chatter Timeline

Stock Ticker for ARQL

Most Active Tweeters for ARQL

UserTweets
@contrarianvue 1

Recent Tweets for ARQL

contrarianvue @contrarianvue
@biotchsavvy Same reason $ARQL got bought out at $2 billion. Single agent activity > combo data. I don’t think this is a fair comparison.
January 16th 2021, 10:01pm
jermz05 @jermz05
@EyeoftheStormZ $APTO which is an oncology play, working on treatment whose closest comp was from $ARQL that was bo… https://t.co/QhOB2GA5Ao
December 31st 2020, 4:12pm
macroaxis @macroaxis
$ARQL new market volatility resembles market https://t.co/jET5Kf0y1b #biotech #stocks #fintech
December 23rd 2020, 11:12am
ProfitMaker_X @ProfitMaker_X
$CYCC hired an $ARQL ex-pat for their CMO job a couple months ago. Now ARQL's former CMO is on their BoD. CYCC ha… https://t.co/9ePSsBJyRq
December 23rd 2020, 3:12am
adar170 @adar170
@Pharmdca Brian Schwartz from $arql just joined board and I m sure helped with this mgmt important
December 18th 2020, 10:12am
GantosJ @GantosJ
@chucknmani4 Thr same question $ARQL's investors were asking for over 3 years, & when they reached the therapeutic… https://t.co/7DcgLUASVq
December 12th 2020, 12:12pm
biostockguru @biostockguru
$TRIL $ARQL Ex CEO newest addition to BoD has a strong track record of M&A https://t.co/D4UFBMrOVr
December 9th 2020, 11:12pm
Gambiste1 @Gambiste1
RT @oncoclinical: $TRIL I wonder whether this is the target of takeover recently mentioned. BOD includes Paolo Pucci $ARQL and scientific b…
December 9th 2020, 9:12pm
oncoclinical @oncoclinical
$TRIL I wonder whether this is the target of takeover recently mentioned. BOD includes Paolo Pucci $ARQL and scient… https://t.co/oQLsjUmfbP
December 9th 2020, 8:12pm
funstocks1 @funstocks1
If my guess is correct, $MRK will soon start combo trials with $ARQL BTKi in hematological malignancies and Keytrud… https://t.co/7QUYv1DbrO
December 9th 2020, 4:12pm
pclark887 @pclark887
@BBSuns Time- $arql took 17 months for responses. 750 dosing has been less than 10. Health of patient- they’ve said… https://t.co/q4DQ25e19v
December 8th 2020, 5:12pm
GrantMBeasley @GrantMBeasley
$ARQL little reminder how biotech goes. Everyone so smart trading for a few shekels. https://t.co/SvIWchJNru
December 7th 2020, 11:12am
GrantMBeasley @GrantMBeasley
@Jessecdghi I don't recall your funny trolling on $ARQL pass.
December 7th 2020, 7:12am
regandarcy @regandarcy
@GantosJ Would love to see $APTO get bought out like $ARQL did.
December 5th 2020, 6:12pm
JacobPlieth @JacobPlieth
@gcbioinv @biotechinvstr When was the last time we saw any data from $ARQL / $MRK ?
December 5th 2020, 1:12pm
tucaman123 @tucaman123
@pawcio2009 Just like $ARQL the Friday before buyout. Was walked down as well.
December 4th 2020, 11:12am
BioValues @BioValues
RT @StockMatusow: Btw, we are pretty big on $CRIS - we think they will hit at #ASH concerning #IRAK4 in #AML Think upstream BTK = $ARQL. Po…
December 1st 2020, 3:12pm
AnExpertOne1 @AnExpertOne1
@pharmacreep @GantosJ While $ARQL is a lower total weight drug, it did take them quite a many shots on goal to get… https://t.co/Wr1mfTO0ZC
December 1st 2020, 9:12am
GantosJ @GantosJ
@AnExpertOne1 @pharmacreep The CLL & AML is large enough for several drugs as we all know. $ARQL hit only BTK, whi… https://t.co/MyAN45Ssb6
December 1st 2020, 9:12am
fierro7676 @fierro7676
RT @GantosJ: It's the same path $ARQL went through, with nodal reduction of 25% to 35% that continue to work over time till they got a PR.…
November 30th 2020, 12:11pm
GantosJ @GantosJ
It's the same path $ARQL went through, with nodal reduction of 25% to 35% that continue to work over time till they… https://t.co/KyJYgBBBqD
November 30th 2020, 10:11am
path1finder @path1finder
$TRIL this year's $ARQL? https://t.co/fv0io1XfLe
November 27th 2020, 11:11am
fierro7676 @fierro7676
RT @mtheory11bio: I’d love to see $APTO present ~ 1.4 to 1.6 micromolar of CG-806 in the 600mg patients at EHA later this week. $ARQL was…
November 26th 2020, 3:11pm
travelsabroad @travelsabroad
RT @semodough: Will we have repeat $ARQL this year at #ASH20. Who ?????
November 25th 2020, 11:11pm
pharmacopolae @pharmacopolae
@semodough Good question. BTW, I do want to thank you for your all your hard work on $ARQL last year (and $TGTX and… https://t.co/fpFC766i6C
November 25th 2020, 9:11am
semodough @semodough
Will we have repeat $ARQL this year at #ASH20. Who ?????
November 25th 2020, 7:11am
wyv_123 @wyv_123
Depending on how you read this, there could have been up to 20 parties interested in parts of $ARQL before $MRK bou… https://t.co/qLYirD0WBa
November 18th 2020, 11:11pm
SEL421 @SEL421
RT @nociFTW: $arql $apto For context, arq 531 started seeing responses regularly in their 7th dose escalation cohort, after ca 10 weeks. Th…
November 14th 2020, 5:11pm
AlexandriaCairo @AlexandriaCairo
RT @jfais20: $TRIL Pucci joining the board is definitely a green flag? As CEO of $ARQL turned the company around from penny stock status t…
November 12th 2020, 6:11pm
wyv_123 @wyv_123
A few weeks ago @srqstockpicker was just talking about $ARQL / $MRK buyout at ASH last year and how that might appl… https://t.co/oc087io8l8
November 12th 2020, 5:11pm
jfais20 @jfais20
$TRIL Pucci joining the board is definitely a green flag? As CEO of $ARQL turned the company around from penny sto… https://t.co/GuVjNAx13x
November 12th 2020, 5:11pm
Varro_Analytics @Varro_Analytics
Well that's interesting... and not very subtle either! ? The $ARQL CEO is joined $TRIL leading into #ASH20... ht… https://t.co/oRervrteyH
November 12th 2020, 4:11pm
eagleowl716 @eagleowl716
RT @semodough: $TRIL picks up $ARQL guy to its board
November 12th 2020, 4:11pm
semodough @semodough
$TRIL picks up $ARQL guy to its board
November 12th 2020, 4:11pm
nociFTW @nociFTW
@drug_smolecules @SalmanHussa01 Essentially there is immortal time bias and survivorship bias on al the $arql patie… https://t.co/i4N3lATG4J
November 12th 2020, 11:11am
nociFTW @nociFTW
$arql $apto For context, arq 531 started seeing responses regularly in their 7th dose escalation cohort, after ca 1… https://t.co/X19DvFUAsM
November 12th 2020, 4:11am
H0U3 @H0U3
RT @drug_smolecules: Anyone notice a difference between the lymphocytosis seen with $ARQL and that of $APTO? https://t.co/ujqLdRmKwD
November 11th 2020, 3:11pm
H0U3 @H0U3
RT @nociFTW: @drug_smolecules $apto $arql What we are comparing is data from the 7th dose level of arq 531 and the 3/4 of cg806. https://t.…
November 11th 2020, 3:11pm
nociFTW @nociFTW
@drug_smolecules $apto $arql What we are comparing is data from the 7th dose level of arq 531 and the 3/4 of cg806. https://t.co/jfVaGXulRh
November 11th 2020, 2:11pm
BiotechTo @BiotechTo
@spence18 @drug_smolecules lymphocytes going down in $ARQL, doesn't seem to be going in $APTO
November 11th 2020, 2:11pm
drug_smolecules @drug_smolecules
Anyone notice a difference between the lymphocytosis seen with $ARQL and that of $APTO? https://t.co/ujqLdRmKwD
November 11th 2020, 2:11pm
BiotekOie @BiotekOie
@no3putts5 What makes $SNSS' drug fake and $ARQL's one real?
November 10th 2020, 4:11pm
Natasha57527098 @Natasha57527098
RT @biotechinvstr: $ARQL 4/6 C481S mut responders AND a Richter's transformation response All responses appear to be ongoing https://t.co…
November 4th 2020, 8:11pm
GantosJ @GantosJ
$ARQL had to get up to 7th cohort 65mg to reach 1st PR in #CLL patient after 15 to 20wks on drug. $APTO is now in… https://t.co/E5IgBFdxJR
October 27th 2020, 1:10pm
FinanceBubble @FinanceBubble
$APTO should build from here going into December with data on their BTK Inhibitor. Looks up $ARQL - this may easi… https://t.co/3v32Qt9dXE
October 23rd 2020, 12:10pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.